Trial Profile
Phase 2 clinical trial of cridanimob (Virexxa) for treatment of advanced and recurrent endometrial cancer in the EU
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2013
Price :
$35
*
At a glance
- Drugs Cridanimod (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 19 Jul 2013 New trial record